• Thursday, Sep 23, 2021
  • Last Update : 12:02 am

BioNTech: Pfizer vaccine likely to be effective against Indian variant

  • Published at 12:18 pm May 21st, 2021
Pfizer vaccine Covid
File photo: Vials labelled 'Covid-19 Coronavirus Vaccine' and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021 Reuters

The company expects their vaccine to protect against infections by 70% to 75%

BioNTech has claimed the Covid-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to be against the South African variant.

The company on Thursday said in a statement Chief Executive Ugur Sahin felt encouraged by recent findings in a scientific paper based on blood analysis of vaccinated individuals, which showed that the antibodies elicited by the vaccine were able to neutralise the Indian variant.

Since the blood tests on the variant that was first detected in South Africa had shown similar results, promising real-world data on the vaccine's effectiveness against the South African variant of about 75% led him to believe that its actual effectiveness against the Indian variant "might be in the same range."

"So far we've had the chance to test our vaccine against more than 30 variants of the virus. It has proven effective against mutations so far," Sahin said earlier, speaking on Turkish television.

Sahin, a German scientist with Turkish parents, spoke in Turkish after virtually attending the Turkish government's science council meeting.

"We expect (our vaccine) to protect against infections by 70% to 75%," he said on TV, in what the company later said was in reference to the South African variant and not directly to the Indian variant.

Since the concerning Covid-19 variant, known as B.1.617.2, was first identified in India, it has ravaged that country and spread to at least 26 nations out of the 53 in the World Health Organization's (WHO) European Region, the organization said.

The WHO's regional director said on Thursday Covid-19 vaccines being deployed in Europe, including the Pfizer/BioNTech shot, appear able to protect against circulating virus variants that have caused concern because they are more easily transmitted.

Sahin was speaking with Turkish Health Minister Fehrettin Koca, who separately said the country recorded less than 10,000 daily new coronavirus cases for the first time since March 1.

Turkey, which briefly was second globally last month in new infections, is using the Pfizer/BioNTech vaccine as well as China's Sinovac Biotech shot in its vaccination program.

81
Facebook 80
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail